Twenty amicus briefs have been filed in support of a petition to the Supreme Court to review the Federal Circuit's decision in Arisioa Diagnostics v. Sequenom. That decision affirmed a district court's determination that Sequenom's patent was nothing more than a patent on a natural phenomenom.  Only one amicus brief in opposition has been filed.  Sequenom's … Continue reading It’s time for the Supreme Court to take another look at what can be patented →